Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

The cannabinoid CB1 receptor antagonist rimonabant (SR141716 — 2006 Review/Other | BudProfiles

Home

Studies

The cannabinoid CB1 receptor antagonist rimonabant...

PositiveReview/Other2006

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism

View Study

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

Cancer - Breast Cancer

Related Studies

Positive

Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances

2025·Laboratory Study -

Inconclusive

Limited 12-hour pharmacokinetic assessment of CBD and CBDA isolates compared to their full-spectrum extracts in healthy adult beagles

2025·Review/Other

N/A

The use of cannabidiol (CBD) to improve sleep: a systematic review

2025·Meta-analysis -

Inconclusive

Recreational drugs repurposed for medicinal use—cannabis

2025·Review/Other

Inconclusive

Specific features of cannabidiol metabolism and excretion during long-term consumption of cannabis

2025·Review/Other

N/A

Phytochemical Modulators of Nociception: A Review of Cannabis Terpenes in Chronic Pain Syndromes

2025·Review/Other

Cannabinoids

SR-x Synthetic Cannabinoids

Organ Systems

Nervous SystemReproductive System

Study Details

Type: Review/Other
Year: 2006
Study ID: #2006013